NCT05196789View on ClinicalTrials.gov

Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study)

RecruitingOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

March 18, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Inherited BMF SyndromeInherited Platelet DisorderHematologic Diseases
Interventions
DIAGNOSTIC_TEST

whole genome and transcriptome sequencing

To perform whole genome/transcriptome analysis of patients in a cohort of up to 350 Australian patients with IBMFS-RD

Trial Locations (1)

Unknown

RECRUITING

Peter MacCallum Cancer Centre, Melbourne

All Listed Sponsors
collaborator

National Health and Medical Research Council, Australia

OTHER

collaborator

University of Melbourne

OTHER

lead

Peter MacCallum Cancer Centre, Australia

OTHER